Results 11 to 20 of about 329,096 (211)
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology [PDF]
Stereotactic radiation approaches are gaining more popularity for the treatment of intracranial as well as extracranial tumors in organs such as the liver and lung.
Steven Eric Finkelstein +6 more
doaj +7 more sources
Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and ...
Atalar Banu +7 more
doaj +2 more sources
Technical know‐how in stereotactic ablative radiotherapy (
Stereotactic ablative radiotherapy (SABR) is an addition to the armamentarium against cancer. The technical requirements for SABR are very stringent, given its very narrow therapeutic window. However, when the principles are strictly followed, it is possible to deliver SABR to extracranial tumours safely and effectively.
Lo, SS +8 more
openaire +9 more sources
Advances in Radiobiology of Stereotactic Ablative Radiotherapy
Radiotherapy (RT) has been developed with remarkable technological advances in recent years. The accuracy of RT is dramatically improved and accordingly high dose radiation of the tumors could be precisely projected.
Bin Qiu +4 more
doaj +3 more sources
Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT).
Tu Chih-Yen +6 more
doaj +2 more sources
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which ...
Julia Malone, BSC +3 more
doaj +3 more sources
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj +2 more sources
Stereotactic ablative radiotherapy for hepatocellular carcinoma
Patients with hepatocellular carcinoma (HCC) often present with underlying liver disease and significant comorbidities, limiting treatment tolerance.
Benjamin Spieler +6 more
openaire +2 more sources
Cardiac stereotactic ablative radiotherapy for control of refractory ventricular tachycardia: initial UK multicentre experience [PDF]
Background Options for patients with ventricular tachycardia (VT) refractory to antiarrhythmic drugs and/or catheter ablation remain limited. Stereotactic radiotherapy has been described as a novel treatment option.Methods Seven patients with recurrent ...
Justin Lee +21 more
doaj +4 more sources
Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
Stereotactic ablative radiotherapy (SABR) has taken a pivotal role in early lung cancer management particularly in the medically inoperable patients. Retrospective studies have shown this to be well tolerated with comparable results to surgery and no ...
Sundus Yahya +4 more
doaj +2 more sources

